Leading science, pioneering therapies
CRM Publications

Estrogen receptor-alpha promotes alternative macrophage activation during cutaneous repair.

TitleEstrogen receptor-alpha promotes alternative macrophage activation during cutaneous repair.
Publication TypeJournal Article
Year of Publication2014
AuthorsCampbell L, Emmerson E, Williams H, Saville CR, Krust A, Chambon P, Mace KA, Hardman MJ
JournalJ Invest Dermatol
Volume134
Issue9
Pagination2447-57
Date Published2014 Sep
ISSN1523-1747
KeywordsAnimals, Estrogen Receptor alpha, Estrogen Receptor beta, Estrogens, Macrophages, Macrophages, Peritoneal, Mice, Inbred C57BL, Mice, Knockout, Nitric Oxide Synthase Type II, Ovariectomy, Signal Transduction, Wound Healing
Abstract

Efficient local monocyte/macrophage recruitment is critical for tissue repair. Recruited macrophages are polarized toward classical (proinflammatory) or alternative (prohealing) activation in response to cytokines, with tight temporal regulation crucial for efficient wound repair. Estrogen acts as a potent anti-inflammatory regulator of cutaneous healing. However, an understanding of estrogen/estrogen receptor (ER) contribution to macrophage polarization and subsequent local effects on wound healing is lacking. Here we identify, to our knowledge previously unreported, a role whereby estrogen receptor α (ERα) signaling preferentially polarizes macrophages from a range of sources to an alternative phenotype. Cell-specific ER ablation studies confirm an in vivo role for inflammatory cell ERα, but not ERβ, in poor healing associated with an altered cytokine profile and fewer alternatively activated macrophages. Furthermore, we reveal intrinsic changes in ERα-deficient macrophages, which are unable to respond to alternative activation signals in vitro. Collectively, our data reveal that inflammatory cell-expressed ERα promotes alternative macrophage polarization, which is beneficial for timely healing. Given the diverse physiological roles of ERs, these findings will likely be of relevance to many pathologies involving excessive inflammation.

DOI10.1038/jid.2014.175
Alternate JournalJ. Invest. Dermatol.
PubMed ID24769859
Publication institute
CRM